Lens On The Scientific Market
Key findings from our industry experts.
Pay Invoice
Latest Blogs
-
NAMs Shift from Policy to Practice: What Life Science R&D Suppliers Need to Know in 2026
March 11, 2026 3:51 pm
Sitemap
Your Data and Privacy
About Us
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.
Video Marketing for Life Science Products
Lots of suppliers have been making short videos of product demonstrations for years now. But Bio-Rad really took the market by storm with its PCR Song video back in January 2008. It was (to my knowledge) the first use of a professionally-produced, viral video in our market. Since then, many others have followed their path […]
Exploring the Epigenetics Market
Based upon a survey of 200 scientists, BioInformatics, LLC benchmarks the state of basic epigenetic research. You can download a free executive summary and detailed table of contents at uour Website. While epigenetics research can employ such commonplace molecular biological techniques as restriction enzyme digestion, primer extension and Southern blotting, it also involves more complex […]
Abcam Surges in the Antibody Market
BioInformatics, LLC – the leading market research and advisory firm serving the life science industry – announces the publication of its latest report, “The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III.” Given the highly fragmented nature of the pre-made catalog antibodies market, this report is designed to create opportunities for differentiation […]
The Market for Antibodies: Keys to Success for Commercial Suppliers
With hundreds of commercial suppliers of antibodies, selecting just the right antibody brings to mind the famous lock and key analogy of antibody-antigen binding—how do scientists find the perfect match? We first answered this question in 2004 and were then asked to update the answer in 2006. Now it’s time to revisit this important market […]
Wall Street Takes Notice of Bio-Tools Market for Stem Cells
Interesting article here: NEW YORK (Fortune) — Biotechs working on cell treatments seem poised to profit from President Obama’s decision to lift the ban on federal funding for embryonic stem cell research and the $15 billion in stimulus money marked for scientific research. But for investors, the best way to play the sector might be […]
The Global Market for Stem Cell Products
The market for stem cell research products is poised for explosive growth with the lifting of restrictions on federal funding. Whether you are an established player in the stem cell market or considering entry into this fast growing market, Capitalizing on New Opportunities for Stem Cell Products is an indispensable resource for: Corporate strategy Business […]
The Arrival of Personal Genetics
BioInformatics, LLC has been working with our good friend John Boyce in helping promote the First Annual Consumer Genetics Show in Boston this coming June. I first met John when he was working with Helicos and retained us to do a number of custom market research studies to help refine their market strategy. John’s new […]
Price war ahead for life science consumables?
I hope by now you’ve heard about our latest report Prospering in a Down Market: Strategies for Life Science Suppliers. We’re of course gratified by the sheer number of companies that have purchased this report (it’s nice to know that with all the major life science suppliers among our clients we’re doing our part to […]
Will the stimulus bill help the life science market?
With an estimated $21.5 billion in federal research and development (R&D) funding signed into law on February 17th, many suppliers are breathing a sigh of relief that the life science market will be immune from the global economic crisis. But it is unclear how quickly these funds will be released, what programs will be funded, […]
How are scientists reacting to the economic crisis?
The life science industry is not immune from the global financial crisis. Pharmaceutical, biotechnology, academic and government labs are bracing for budget freezes and staff reductions. During this tumultuous time in our industry, the opportunity for life science suppliers to thrive-rather than survive-will be predicated on a detailed understanding of how labs will allocate 2009 […]